Robert J More's Net Worth

$9.93 Million

Estimate Recalculated Nov 11, 2024 07:54AM EST

Who is Robert J More

Robert J More has an estimated net worth of $9.93 Million. This is based on reported shares across multiple companies, which include Volcano Corp, Orexigen Therapeutics, Inc., IOMAI CORP, Allakos Inc., GLAUKOS Corp, Tyra Biosciences, Inc., Vanda Pharmaceuticals Inc., Vir Biotechnology, Inc., NUVASIVE INC, Sienna Biopharmaceuticals, Inc., NOVACEA INC, CADENCE PHARMACEUTICALS INC, SANTARUS INC, Somaxon Pharmaceuticals, Inc., and Northstar Neuroscience, Inc..

SEC CIK

Robert J More's CIK is 0001207792

Past Insider Trading and Trends

2007 was Robert J More's most active year for acquiring shares with 3 total transactions. Robert J More's most active month to acquire stocks was the month of April. 2021 was Robert J More's most active year for disposing of shares, totalling 29 transactions. Robert J More's most active month to dispose stocks was the month of February. 2019 saw Robert J More paying a total of $250,000.00 for 185,822 shares, this is the most they've acquired in one year. In 2021 Robert J More cashed out on 105,948 shares for a total of $6,639,548.10, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allakos Inc.

Investor
Updated Mar 05, 2021
Form 4
-100.00%
-32.55K
$114.22
-$3.72M
Mar 05, 2021
2.07M
Sale
Mar 03 - Mar 05
Form 4
-100.00%
-11.54K
$71.58
-$825.94K
May 20, 2020
2.56M
Sale
May 18
Form 4
-8.32%
-958.55K
Jan 24, 2020
10.56M
Disposition
Jan 22
Form 4
2.22%
250.00K
$18.00
Jul 23, 2018
11.52M
Purchase
Jul 23
Form 3
Jul 18, 2018
Showing 5 results

Volcano Corp

Investor
Updated Jul 18, 2008
Form 4
-20.03%
-678.37K
$14.49
-$226.84K
Jul 18, 2008
2.71M
Sale
Jul 16
Form 4
33.16%
18.32K
Jun 09, 2008
73.56K
Acquisition
Apr 24
Form 4
-14.83%
-589.88K
$12.98
-$176.70K
Apr 10, 2008
3.39M
Sale
Apr 08
Form 4
2,866.60%
53.38K
Sep 12, 2007
55.24K
Acquisition
Sep 12
Form 4/A
24.09K
Jun 14, 2007
24.09K
Acq/Dis
May 25
Form 4/A
-100.00%
-22.23K
$20.12
-$447.27K
Jun 06, 2007
Sale
May 31
Form 4
-100.00%
-22.23K
$20.12
-$447.27K
Jun 01, 2007
Sale
May 31
Form 4
22.23K
May 29, 2007
22.23K
Acq/Dis
May 25
Form 4
-18.20%
-20.42K
$19.25
-$393.07K
May 22, 2007
91.78K
Sale
May 18
Form 4
-15.18%
-721.17K
May 11, 2007
4.03M
Disposition
May 10
Form 4/A
-15.47%
-889.69K
$16.75
-$14.90M
Dec 11, 2006
4.86M
Sale
Dec 06
Form 4
-15.47%
-889.69K
$16.75
-$14.90M
Dec 08, 2006
4.86M
Sale
Dec 06
Form 4
Jun 20, 2006
5.75M
Options
Jun 20
Form 3
Jun 14, 2006
Showing 14 results

Orexigen Therapeutics, Inc.

Investor
Updated Nov 29, 2007
Form 4
-19.84%
-902.43K
$14.27
-$299.67K
Nov 29, 2007
3.65M
Sale
Nov 27
Form 4
13.05%
525.00K
$12.00
May 01, 2007
4.55M
Purchase
May 01
Form 3
Apr 25, 2007
260.00K
Showing 3 results

IOMAI CORP

Investor
Updated Feb 07, 2006
Form 4
Feb 07, 2006
1.74M
Options
Feb 06
Form 3/A
Feb 01, 2006
Form 3
Jan 25, 2006
Showing 3 results

GLAUKOS Corp

Investor
Updated Jun 30, 2015
Form 4
5.00K
$18.00
$90.00K
Jun 30, 2015
5.00K
Purchase
Jun 24
Form 3
Jun 24, 2015
Showing 2 results

Tyra Biosciences, Inc.

Investor
Updated May 31, 2024
Form 4
18.60K
May 31, 2024
18.60K
Grant
May 29
Form 4
14.50K
Jun 02, 2023
14.50K
Grant
May 31
Form 4
14.50K
Jun 15, 2022
14.50K
Grant
Jun 13
Form 4
158.21%
2.50M
$16.00
Sep 17, 2021
4.08M
Purchase
Sep 17
Form 3
Sep 14, 2021
112.93K
Showing 5 results

Vanda Pharmaceuticals Inc.

Investor
Updated Dec 13, 2006
Form 4
-22.64%
-584.29K
$25.62
-$330.50K
Dec 13, 2006
2.00M
Sale
Dec 12
Form 4
-19.67%
-623.33K
Nov 03, 2006
2.55M
Disposition
Nov 03
Form 4
-69.79%
-7.40M
Apr 18, 2006
3.20M
Options
Apr 18
Form 3
Apr 12, 2006
Showing 4 results

Vir Biotechnology, Inc.

Investor
Updated Jun 03, 2024
Form 4
62.04%
24.00K
Jun 03, 2024
558.57K
Grant
May 30
Form 4
Oct 20, 2023
534.57K
Acq/Dis
Oct 19
Form 4
46.29%
18.08K
May 24, 2023
546.63K
Grant
May 22
Form 4
Jun 13, 2022
528.55K
Acq/Dis
Jun 09
Form 4
53.33%
19.21K
May 25, 2022
541.36K
Grant
May 23
Form 4
-21.72%
-10.00K
$40.17
-$356.98K
Aug 02, 2021
522.14K
Sale
ScheduledJul 01 - Jul 29
Form 4
-20.23%
-11.67K
$35.56
-$415.01K
Jul 19, 2021
532.14K
Sale
ScheduledJul 15
Form 4
-16.82%
-11.67K
$44.92
-$524.27K
Jul 06, 2021
543.81K
Sale
ScheduledJul 01
Form 4
-14.40%
-11.67K
$43.95
-$512.84K
Jun 21, 2021
555.48K
Sale
ScheduledJun 17
Form 4
-12.59%
-11.67K
$44.56
-$520.03K
Jun 07, 2021
567.15K
Sale
ScheduledJun 03
Form 4
3.51%
3.37K
May 25, 2021
585.57K
Grant
May 21
Form 4
-11.55%
-11.67K
$44.50
-$519.35K
May 24, 2021
575.45K
Sale
ScheduledMay 20
Form 4/A
24.36K
Oct 13, 2020
24.36K
Grant
May 21
Form 4
28.89K
May 26, 2020
28.89K
Grant
May 21
Form 4/A
May 07, 2020
70.65K
Form 4
-20.51%
-18.46K
$28.00
-$516.85K
May 05, 2020
1.04M
Sale
May 01
Form 4
Oct 18, 2019
2.01M
Options
Oct 16
Form 3
Oct 10, 2019
Showing 18 results

NUVASIVE INC

Investor
Updated May 12, 2004
Form 3
May 12, 2004
8.00K
Showing 1 results

Sienna Biopharmaceuticals, Inc.

Investor
Updated Jun 03, 2019
Form 4
25.00K
Jun 03, 2019
25.00K
Grant
May 30
Form 4
64.13%
100.00K
$2.50
$250.00K
Feb 26, 2019
255.94K
Purchase
Feb 22
Form 4
10.00K
Jun 04, 2018
10.00K
Grant
Jun 01
Form 4
-12.02%
-24.43K
$18.80
-$459.38K
Mar 29, 2018
178.82K
Sale
Mar 28 - Mar 29
Form 4
Aug 01, 2017
203.25K
Options
Aug 01
Form 3
Jul 26, 2017
34.07K
Showing 6 results

NOVACEA INC

Investor
Updated Jun 06, 2007
Form 4
-24.98%
-24.50K
$11.26
-$275.87K
Jun 06, 2007
73.58K
Sale
Jun 06
Form 4
-20.09%
-834.30K
Jun 05, 2007
3.32M
Disposition
Jun 04
Form 4
7.92M
$6.50
May 16, 2006
4.25M
Purchase
May 15
Form 3
May 09, 2006
157.50K
Showing 4 results

CADENCE PHARMACEUTICALS INC

Investor
Updated Oct 24, 2006
Form 3
Oct 24, 2006
27.50K
Showing 1 results

SANTARUS INC

Investor
Updated Apr 08, 2004
Form 4
0.03%
720.00
Apr 08, 2004
2.79M
Options
Apr 06
Form 3
Mar 31, 2004
Showing 2 results

Somaxon Pharmaceuticals, Inc.

Investor
Updated Dec 22, 2006
Form 4
-24.50%
-567.85K
$13.52
-$87.33K
Dec 22, 2006
1.75M
Sale
Dec 21
Form 4
-20.00%
-6.46K
$13.03
-$84.16K
Sep 20, 2006
25.84K
Sale
Sep 18
Form 4
-19.78%
-565.16K
Sep 14, 2006
2.29M
Disposition
Sep 13
Form 4
-83.33%
-14.45M
Dec 20, 2005
2.89M
Options
Dec 20
Form 3
Dec 14, 2005
19.17K
Showing 5 results

Northstar Neuroscience, Inc.

Investor
Updated May 04, 2006
Form 3
May 04, 2006
3.33K
Showing 1 results